These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 18050205

  • 1. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
    Zhang L, Bertucci AM, Smith KA, Xu L, Datta SK.
    Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential.
    Yang P, Zhang Y, Ping L, Gao XM.
    Int Immunopharmacol; 2007 Nov; 7(11):1414-21. PubMed ID: 17761345
    [Abstract] [Full Text] [Related]

  • 3. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
    Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW.
    Cancer Res; 2004 May 15; 64(10):3668-78. PubMed ID: 15150127
    [Abstract] [Full Text] [Related]

  • 4. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
    Jacob S, Laury-Kleintop L, Lanza-Jacoby S.
    J Surg Res; 2008 May 01; 146(1):135-42. PubMed ID: 17950326
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W, Yu CH, Hu KQ.
    Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255
    [Abstract] [Full Text] [Related]

  • 6. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L, Chen W, Xie X, He Y, Bai X.
    Exp Oncol; 2008 Mar 15; 30(1):42-51. PubMed ID: 18438340
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J, Yuan J, Li L, Liu H, Qin R, Qin W, Chen B, Wang H, Wu K.
    Biomed Pharmacother; 2009 Mar 15; 63(3):241-8. PubMed ID: 18617357
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH, Xiong XY, Zhang BL, Lin GC, Shi YX, Liu ZG, Meng JR, Zhou YM, Mei QB.
    Acta Pharmacol Sin; 2005 Dec 15; 26(12):1505-11. PubMed ID: 16297351
    [Abstract] [Full Text] [Related]

  • 9. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2008 Jul 15; 76(2):179-87. PubMed ID: 18547544
    [Abstract] [Full Text] [Related]

  • 10. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY, Choi HK, Lee KJ, Jung JY, Hur GY, Jung KH, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Yoo SH.
    J Immunother; 2009 Jan 15; 32(1):22-8. PubMed ID: 19307990
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y, Liu J, Wang LZ, Zhang WY, Zhu XZ.
    Acta Pharmacol Sin; 2005 Aug 15; 26(8):952-8. PubMed ID: 16038627
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2007 Feb 15; 82(2):229-38. PubMed ID: 17207548
    [Abstract] [Full Text] [Related]

  • 13. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA, Narayanan NK, Pttman B, Reddy BS.
    Prostate; 2006 Feb 15; 66(3):257-65. PubMed ID: 16175586
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 15. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S.
    Arthritis Rheum; 2003 Jun 15; 48(6):1612-21. PubMed ID: 12794829
    [Abstract] [Full Text] [Related]

  • 16. Human lupus T cells resist inactivation and escape death by upregulating COX-2.
    Xu L, Zhang L, Yi Y, Kang HK, Datta SK.
    Nat Med; 2004 Apr 15; 10(4):411-5. PubMed ID: 14991050
    [Abstract] [Full Text] [Related]

  • 17. COX-2 expression in chondrosarcoma: a role for celecoxib treatment?
    Schrage YM, Machado I, Meijer D, Briaire-de Bruijn I, van den Akker BE, Taminiau AH, Kalinski T, Llombart-Bosch A, Bovée JV.
    Eur J Cancer; 2010 Feb 15; 46(3):616-24. PubMed ID: 20004565
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 15; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 19. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 20. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.
    Kaliyaperumal A, Michaels MA, Datta SK.
    J Immunol; 1999 May 15; 162(10):5775-83. PubMed ID: 10229810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.